Blincyto (blinatumomab)

pCPA File Number: 20968
Negotiation Status:
Concluded with an LOI
Indication(s):
Pediatric Acute Lymphoblastic Leukemia (ALL)
Sponsor/Manufacturer:
Amgen Canada Inc.
CADTH Project Number:
pCODR 10099
pCPA Engagement Letter Issued:
Negotiation Process Concluded: